Detalhe da pesquisa
1.
Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.
J Clin Immunol
; 42(5): 1071-1082, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486339
2.
Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations.
J Clin Immunol
; 42(6): 1193-1204, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507130
3.
Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
Pediatr Allergy Immunol
; 32(8): 1804-1812, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289170
4.
SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
J Clin Immunol
; 41(7): 1502-1506, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34109505